TrialDrug safety2021

Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.

Gilles Defer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.